| Revlimid - High Dose Dex Dosage Schedule: Month* 1-4 | ||||||
|---|---|---|---|---|---|---|
| Day 1 Rev + dex |
Day 2 Rev + dex |
Day 3 Rev + dex |
Day 4 Rev + dex |
Day 5 Rev |
Day 6 Rev |
Day 7 Rev |
| Day 8 Rev |
Day 9 Rev + dex |
Day 10 Rev + dex |
Day 11 Rev + dex |
Day 12 Rev + dex |
Day 13 Rev |
Day 14 Rev |
| Day 15 Rev |
Day 16 Rev |
Day 17 Rev + dex |
Day 18 Rev + dex |
Day 19 Rev + dex |
Day 20 Rev + dex |
Day 21 Rev |
| Day 22 - 28: Rest | ||||||
Rev + dex = Revlimid plus dexamethasone (Revlimid-dex)
* 28 day treatment cycle
 
| Revlimid- high dose dex dosage schedule: Month* 5 and beyond | ||||||
|---|---|---|---|---|---|---|
| Day 1 Rev + dex |
Day 2 Rev + dex |
Day 3 Rev + dex |
Day 4 Rev + dex |
Day 5 Rev |
Day 6 Rev |
Day 7 Rev |
| Day 8 Rev |
Day 9 Rev |
Day 10 Rev |
Day 11 Rev |
Day 12 Rev |
Day 13 Rev |
Day 14 Rev |
| Day 15 Rev |
Day 16 Rev |
Day 17 Rev |
Day 18 Rev |
Day 19 Rev |
Day 20 Rev |
Day 21 Rev |
| Day 22 - 28: Rest | ||||||
Rev + dex = Revlimid plus dexamethasone (Revlimid-dex)
* 28 day treatment cycle
| Revlimid-Low Dex Dose Schedule: Monthly* Schedule | ||||||
|---|---|---|---|---|---|---|
| D1 Rev + dex |
D2 Rev |
D3 Rev |
D4 Rev |
D5 Rev |
D6 Rev |
D7 Rev |
| D8 Rev + dex |
D9 Rev |
D10 Rev |
D11 Rev |
D12 Rev |
D13 Rev |
D14 Rev |
| D15 Rev + dex |
D16 Rev |
D17 Rev |
D18 Rev |
D19 Rev |
D20 Rev |
D21 Rev |
| D22 dex (No Rev) |
||||||
| D23 – D28: Rest | ||||||
D = Day; Rev + dex = Revlimid plus dexamethasone (Revlimid-dex)
* 28 day treatment cycle
| Common Side Effects: Large Revlimid/Dex Studies (Phase III Trials) | ||||
|---|---|---|---|---|
| Side Effect | Revlimid/Dex(n=346) | Placebo/Dex(n=345) | ||
| Mild or Moderate (grade 1-2) | Severe (grade 3-4) | Mild or Moderate (grade 1-2) | Severe (grade 3-4) | |
| Constipation | 37% | 2% | 19% | 0% |
| Fatigue | 32% | 6% | 33% | 4% |
| Insomnia | 32% | 0% | 37% | 0% |
| Muscle cramp | 30% | 0% | 21% | 0% |
| Diarrhea | 27% | 2% | 24% | 0.6% |
| Low white blood cell count (neutropenia)* | 7% | 21% | 2% | 3% |
| Anemia* | 17% | 8% | 14% | 3% |
| Weakness/loss of strength (asthenia) | 19% | 4% | 20% | 5% |
| Fever | 22% | 1% | 17% | 2% |
| Nausea | 22% | 0% | 19% | 0% |
| Headache | 21% | 0% | 21% | 0% |
| Swelling of arms/legs | 21% | 0% | 19% | 0% |
| Dizziness | 21% | 0% | 15% | 0% |
| Shortness of breath | 17% | 3% | 13% | 2% |
| Tremor (involuntary movements/shakiness) | 20% | 0% | 7% | 0% |
| Decreased weight | 18% | 0% | 14% | 0% |
| Low platelet counts (thrombocytopenia)* | 7% | 10% | 4% | 6% |
| Rash** | 16% | 0% | 8% | 0% |
| Back pain | 15% | 0% | 14% | 0% |
| Elevated blood sugar | 8% | 7% | 6% | 8% |
| Muscle weakness | 10% | 5% | 12% | 3% |
| Blood clots* Vein (Deep Vein Thrombosis, DVT) Lung (Pulmonary Embolism) | 1% 0% |
7% 3% |
0% 0% |
3% 1% |
* Includes life-threatening side effect (grade 4) in >1% of patients
** Another study did not show an increase in rash
| Starting Dose for Patients with Renal Impairment | |
|---|---|
| Degree of renal impairment | Revlimid dose |
| Moderate* | 10mg every 24 hours |
| Severe+ | 15mg every 48 hours |
| End Stage, requiring dialysis++ | 5 mg once daily. On the dialysis days, Revlimid should be given after dialysis. |
*Moderate: 30 < CLcr < 60mL/min
+Severe: CLcr < 30 mL/min; dialysis not required
++End Stage, requiring dialysis: CLcr < 30 mL/min
|
Guidelines for Additional Revlimid Dose Changes for Serious Side Effects* Low Platelet Counts |
|
|---|---|
| When platelet counts: | Recommendation |
| Fall to <30,000/mcL Return to ≥30,000/mcL |
|
| For each subsequent drop <30,000/mcL Return to ≥30,000/mcL |
|
*Typical starting dose of Revlimid is 25mg/day, Minimum dose: 5 mg/day
| Low White Blood Cell Counts | |
|---|---|
| When white blood cells: | Recommendation |
| Fall to <1000/mcL Return to ≥1000/mcL and low white blood cells is the only side effect |
|
| Return to ≥1000/mcL , but the patient is experiencing other side effects |
|
| For each subsequent drop <1000/mcL Return to ≥1000/mcL |
|
*Typical starting dose of Revlimid is 25mg/day, Minimum dose: 5 mg/day
| Other Serious Side Effects (Potentially Life-Threatening, Grade 3 or 4) |
|---|
| For other serious side effects considered to be related to Revlimid, your doctor will temporarily stop treatment. After the side effect has significantly improved (to a mild or moderate level or ≤ grade 2) Revlimid can be re-started at a lower dose. |





